Safe S, Kothari J, Hailemariam A et al. Health benefits of Coffee Consumption for Cancer and other diseases and mechanisms of Action. Int J Mol Sci. 2023; 24(3).

Socha M, Sobiech KA, Eating, Habits. Risk of Breast Cancer, and Diet-Dependent Quality of Life in Postmenopausal Women after Mastectomy. J Clin Med. 2022; 11(15).

Guerriero G, Berni R, Munoz-Sanchez JA et al. Production of Plant secondary metabolites: examples, Tips and suggestions for Biotechnologists. Genes (Basel). 2018; 9(6).

Lester SC, Bose S, Chen YY, et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med. 2009;133(10):1515–38.

Article  PubMed  Google Scholar 

Bhattacharya T, Dutta S, Akter R et al. Role of Phytonutrients in Nutrigenetics and Nutrigenomics Perspective in Curing Breast Cancer. Biomolecules. 2021; 11(8).

Kapinova A, Kubatka P, Golubnitschaja O, et al. Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention. Environ Health Prev Med. 2018;23(1):36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meneses AF, Mendes A, Rocha DC, et al. Association of coffee intake and its polyphenols with mammographic findings in women who visited the Brazilian Public Health Service. Nutr Hosp. 2023;40(2):377–83.

PubMed  Google Scholar 

Sanchez-Quesada C, Romanos-Nanclares A, Navarro AM, et al. Coffee consumption and breast cancer risk in the SUN project. Eur J Nutr. 2020;59(8):3461–71.

Article  PubMed  Google Scholar 

Azzeh FS, Hasanain DM, Qadhi AH et al. Consumption of Food Components of the Mediterranean Diet decreases the risk of breast Cancer in the Makkah Region, Saudi Arabia: a case-control study. Front Nutr. 2022; 9863029.

Farvid MS, Spence ND, Rosner BA, et al. Post-diagnostic coffee and tea consumption and breast cancer survival. Br J Cancer. 2021;124(11):1873–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Ma L. The association between coffee intake and breast cancer risk: a meta-analysis and dose-response analysis using recent evidence. Ann Palliat Med. 2021;10(4):3804–16.

Article  PubMed  Google Scholar 

Yaghjyan L, McLaughlin E, Lehman A, et al. Associations of coffee/caffeine consumption with postmenopausal breast cancer risk and their interactions with postmenopausal hormone use. Eur J Nutr. 2022;61(7):3449–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sinnadurai S, Okabayashi S, Kawamura T, et al. Intake of common alcoholic and non-alcoholic beverages and breast Cancer risk among Japanese women: findings from the Japan Collaborative Cohort Study. Asian Pac J Cancer Prev. 2020;21(6):1701–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nigra AD, de Almeida Bauer Guimaraes D, Prucca CG et al. Antitumor effects of Freeze-dried Robusta Coffee (Coffea canephora) extracts on breast Cancer cell lines. Oxid Med Cell Longev. 2021; 20215572630.

Tawfike A, Attia EZ, Desoukey SY, et al. New bioactive metabolites from the elicited marine sponge-derived bacterium Actinokineospora spheciospongiae sp. nov. AMB Express. 2019;9(1):12.

Article  PubMed  PubMed Central  Google Scholar 

Olano C, Mendez C, Salas JA. Antitumor compounds from marine actinomycetes. Mar Drugs. 2009;7(2):210–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang J, Wu W, Yang F, et al. Marine sponge-derived smenospongine preferentially eliminates breast cancer stem-like cells via p38/AMPKalpha pathways. Cancer Med. 2018;7(8):3965–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elmallah MIY, Cogo S, Constantinescu AA et al. Marine actinomycetes-Derived secondary metabolites overcome TRAIL-Resistance via the intrinsic pathway through downregulation of Survivin and XIAP. Cells. 2020; 9(8).

Kolak A, Kaminska M, Sygit K, et al. Primary and secondary prevention of breast cancer. Ann Agric Environ Med. 2017;24(4):549–53.

Article  PubMed  Google Scholar 

Lesniczak B, Krasomski G, Oszukowski P, et al. Incidence of and mortality from breast cancer among women in Poland in the years 2001–2010. Prz Menopauzalny. 2014;13(6):344–7.

PubMed  PubMed Central  Google Scholar 

Coughlin SS, Smith SA. The impact of the natural, social, built, and Policy environments on breast Cancer. J Environ Health Sci. 2015; 1(3).

Bourdon JC, Deguin-Chambon V, Lelong JC, et al. Further characterisation of the p53 responsive element–identification of new candidate genes for trans-activation by p53. Oncogene. 1997;14(1):85–94.

Article  CAS  PubMed  Google Scholar 

Buckbinder L, Talbott R, Velasco-Miguel S, et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature. 1995;377(6550):646–9.

Article  CAS  PubMed  Google Scholar 

Cai Q, Dozmorov M, Oh Y. IGFBP-3/IGFBP-3 receptor system as an Anti-tumor and Anti-metastatic Signaling in Cancer. Cells. 2020; 9(5).

Waghray D, Zhang Q. Inhibit or evade Multidrug Resistance P-Glycoprotein in Cancer Treatment. J Med Chem. 2018;61(12):5108–21.

Article  CAS  PubMed  Google Scholar 

Brockman JA, Gupta RA, Dubois RN. Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology. 1998;115(5):1049–55.

Article  CAS  PubMed  Google Scholar 

Wang C, Fu M, D’Amico M, et al. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. Mol Cell Biol. 2001;21(9):3057–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Mesery M, Al-Gayyar M, Salem H et al. Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides. Cell Div. 2009; 46.

Schirner M, Hoffmann J, Menrad A, et al. Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models. Clin Cancer Res. 1998;4(5):1331–6.

CAS  PubMed  Google Scholar 

Chen M, Xiao C, Jiang W et al. Capsaicin inhibits proliferation and induces apoptosis in breast Cancer by Down-regulating FBI-1-Mediated NF-kappaB pathway. Drug Des Devel Ther. 2021; 15125–40.

Parton M, Dowsett M, Smith I. Studies of apoptosis in breast cancer. BMJ. 2001;322(7301):1528–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin P, Liang Z, Wang M. Caffeine consumption and mortality in populations with different weight statuses: an analysis of NHANES 1999–2014. Nutrition. 2022; 102111731.

Liu D, Li ZH, Shen D, et al. Association of Sugar-Sweetened, artificially sweetened, and Unsweetened Coffee Consumption with all-cause and cause-specific mortality: a large prospective cohort study. Ann Intern Med. 2022;175(7):909–17.

Article  PubMed  Google Scholar 

Torres-Collado L, Compan-Gabucio LM, Gonzalez-Palacios S et al. Coffee Consumption and All-Cause, Cardiovascular, and Cancer Mortality in an adult Mediterranean Population. Nutrients. 2021; 13(4).

Carter P, Yuan S, Kar S, et al. Coffee consumption and cancer risk: a mendelian randomisation study. Clin Nutr. 2022;41(10):2113–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim SY, Yoo DM, Min C et al. Association between Coffee Consumption/Physical Exercise and gastric, hepatic, Colon, breast, uterine cervix, lung, thyroid, prostate, and bladder Cancer. Nutrients 2021; 13(11).

Pu X, Storr SJ, Zhang Y, et al. Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival. Apoptosis. 2017;22(3):357–68.

Article  CAS  PubMed  Google Scholar 

Baxter RC. IGF binding proteins in cancer: mechanistic and clinical insights. Nat Rev Cancer. 2014;14(5):329–41.

Article  CAS  PubMed  Google Scholar 

Clemmons DR. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol. 1998;140(1–2):19–24.

Article  CAS  PubMed  Google Scholar 

Ludwig RL, Bates S, Vousden KH. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol Cell Biol. 1996;16(9):4952–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang YS, Wang L, Liu D, et al. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer. Clin Cancer Res. 2002;8(12):3669–75.

CAS  PubMed  Google Scholar 

Fu T, Pappou EP, Guzzetta AA, et al. IGFBP-3 gene methylation in primary Tumor predicts recurrence of stage II colorectal cancers. Ann Surg. 2016;263(2):337–44.

Article  PubMed  Google Scholar 

Pernia O, Belda-Iniesta C, Pulido V, et al. Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy. Epigenetics. 2014;9(11):1446–53.

Article